BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
85.68
-1.78 (-2.04%)
At close: Mar 27, 2026, 4:00 PM EDT
85.82
+0.14 (0.16%)
After-hours: Mar 27, 2026, 7:10 PM EDT
BioNTech SE Market Cap
BioNTech SE has a market cap or net worth of $20.56 billion as of March 27, 2026. Its market cap has decreased by -12.09% in one year.
Market Cap
20.56B
Enterprise Value
4.74B
1-Year Change
-12.09%
Ranking
Category
Stock Price
$85.68
Market Cap Chart
Since October 10, 2019, BioNTech SE's market cap has increased from $2.99B to $20.56B, an increase of 586.50%. That is a compound annual growth rate of 34.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 20.56B | -10.18% |
| Dec 31, 2025 | 22.89B | -16.21% |
| Dec 31, 2024 | 27.32B | 8.89% |
| Dec 29, 2023 | 25.09B | -31.28% |
| Dec 30, 2022 | 36.51B | -41.37% |
| Dec 31, 2021 | 62.26B | 217.21% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 10, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 31.38B |
| Insmed | 31.32B |
| Royalty Pharma | 26.74B |
| Moderna | 19.65B |
| Roivant Sciences | 18.98B |
| Revolution Medicines | 18.33B |
| Incyte | 17.97B |
| Genmab | 15.93B |